APO Research
Talk to an analyst

APO RESEARCH · REPORT

Health Product Testing

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Health Product Testing Market Outlook and Growth Opportunities 2026

2 May 2026196 pages

Choose your research edition.

Industry ResearchHealth Product Testing Industry Research Report 2026115 pages · $2,950 USDIndustry Growth & TrendsGlobal Health Product Testing Industry Growth and Trends Forecast to 2032101 pages · $3,450 USDMarket StructureGlobal Health Product Testing Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032196 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Health Product Testing Market Outlook and Growth Opportunities 2026196 pages · $4,250 USDMarket Analysis & ForecastGlobal Health Product Testing Market Analysis and Forecast 2026-2032236 pages · $4,950 USD

Market perspective

The global Health Product Testing market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Health Product Testing is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Health Product Testing is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Health Product Testing is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Health Product Testing market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Health Product Testing market include CPT Labs, Bureau Veritas, Eurofins Scientific, ESR, UL (Underwriters Laboratories), Intertek Group, SGS SA, TUV SUD and NSF International, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Health Product Testing market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Health Product Testing and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Health Product Testing revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Health Product Testing market.

Health Product Testing Segment by Company

CPT Labs

Bureau Veritas

Eurofins Scientific

ESR

UL (Underwriters Laboratories)

Intertek Group

SGS SA

TUV SUD

NSF International

ALS Limited

QIMA (AsiaInspection)

TÜV Rheinland Group

Health Product Testing Segment by Type

Ingredient Testing

Heavy Metal and Hazardous Substance Detection

Microbial Indicator Detection

Physical and Chemical Indicator Monitoring

Toxicology Experiments

Functional Verification

Health Product Testing Segment by Application

Personal

Enterprise

Health Product Testing Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Health Product Testing status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Health Product Testing key companies, revenue, market share, and recent developments.

3. To split the Health Product Testing breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Health Product Testing market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Health Product Testing significant trends, drivers, influence factors in global and regions.

6. To analyze Health Product Testing competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Health Product Testing market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Health Product Testing and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Health Product Testing.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Health Product Testing industry.

Chapter 3: Detailed analysis of Health Product Testing company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Health Product Testing in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Health Product Testing in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Health Product Testing Industry Trends Table 2. Health Product Testing Industry Drivers Table 3. Health Product Testing Industry Opportunities and Challenges Table 4. Health Product Testing Industry Restraints Table 5. Global Health Product Testing Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Health Product Testing Revenue Share by Company (2021-2026) Table 7. Global Health Product Testing Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Health Product Testing Key Company Manufacturing Base & Headquarters Table 9. Global Health Product Testing Company, Product Type & Application Table 10. Global Health Product Testing Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Health Product Testing by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Ingredient Testing Table 15. Significant Companies of Heavy Metal and Hazardous Substance Detection Table 16. Significant Companies of Microbial Indicator Detection Table 17. Significant Companies of Physical and Chemical Indicator Monitoring Table 18. Significant Companies of Toxicology Experiments Table 19. Significant Companies of Functional Verification Table 20. Global Health Product Testing Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 21. Global Health Product Testing Sales Value by Type (2021-2026) & (US$ Million) Table 22. Global Health Product Testing Sales Value by Type (2027-2032) & (US$ Million) Table 23. Global Health Product Testing Sales Value Share by Type (2021-2026) Table 24. Global Health Product Testing Sales Value Share by Type (2027-2032) Table 25. Significant Companies of Personal Table 26. Significant Companies of Enterprise Table 27. Global Health Product Testing Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 28. Global Health Product Testing Sales Value by Application (2021-2026) & (US$ Million) Table 29. Global Health Product Testing Sales Value by Application (2027-2032) & (US$ Million) Table 30. Global Health Product Testing Sales Value Share by Application (2021-2026) Table 31. Global Health Product Testing Sales Value Share by Application (2027-2032) Table 32. Global Health Product Testing Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 33. Global Health Product Testing Sales Value by Region (2021-2026) & (US$ Million) Table 34. Global Health Product Testing Sales Value Share by Region (2021-2026) Table 35. Global Health Product Testing Sales Value by Region (2027-2032) & (US$ Million) Table 36. Global Health Product Testing Sales Value Share by Region (2027-2032) Table 37. Global Health Product Testing Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 38. Global Health Product Testing Sales Value by Country (2021-2026) & (US$ Million) Table 39. Global Health Product Testing Sales Value Market Share by Country (2021-2026) Table 40. Global Health Product Testing Sales Value by Country (2027-2032) & (US$ Million) Table 41. Global Health Product Testing Sales Value Market Share by Country (2027-2032) Table 42. CPT Labs Company Information Table 43. CPT Labs Business Overview Table 44. CPT Labs Health Product Testing Revenue (US$ Million) and Gross Margin (2021-2026) Table 45. CPT Labs Health Product Testing Product Portfolio Table 46. CPT Labs Recent Development Table 47. Bureau Veritas Company Information Table 48. Bureau Veritas Business Overview Table 49. Bureau Veritas Health Product Testing Revenue (US$ Million) and Gross Margin (2021-2026) Table 50. Bureau Veritas Health Product Testing Product Portfolio Table 51. Bureau Veritas Recent Development Table 52. Eurofins Scientific Company Information Table 53. Eurofins Scientific Business Overview Table 54. Eurofins Scientific Health Product Testing Revenue (US$ Million) and Gross Margin (2021-2026) Table 55. Eurofins Scientific Health Product Testing Product Portfolio Table 56. Eurofins Scientific Recent Development Table 57. ESR Company Information Table 58. ESR Business Overview Table 59. ESR Health Product Testing Revenue (US$ Million) and Gross Margin (2021-2026) Table 60. ESR Health Product Testing Product Portfolio Table 61. ESR Recent Development Table 62. UL (Underwriters Laboratories) Company Information Table 63. UL (Underwriters Laboratories) Business Overview Table 64. UL (Underwriters Laboratories) Health Product Testing Revenue (US$ Million) and Gross Margin (2021-2026) Table 65. UL (Underwriters Laboratories) Health Product Testing Product Portfolio Table 66. UL (Underwriters Laboratories) Recent Development Table 67. Intertek Group Company Information Table 68. Intertek Group Business Overview Table 69. Intertek Group Health Product Testing Revenue (US$ Million) and Gross Margin (2021-2026) Table 70. Intertek Group Health Product Testing Product Portfolio Table 71. Intertek Group Recent Development Table 72. SGS SA Company Information Table 73. SGS SA Business Overview Table 74. SGS SA Health Product Testing Revenue (US$ Million) and Gross Margin (2021-2026) Table 75. SGS SA Health Product Testing Product Portfolio Table 76. SGS SA Recent Development Table 77. TUV SUD Company Information Table 78. TUV SUD Business Overview Table 79. TUV SUD Health Product Testing Revenue (US$ Million) and Gross Margin (2021-2026) Table 80. TUV SUD Health Product Testing Product Portfolio Table 81. TUV SUD Recent Development Table 82. NSF International Company Information Table 83. NSF International Business Overview Table 84. NSF International Health Product Testing Revenue (US$ Million) and Gross Margin (2021-2026) Table 85. NSF International Health Product Testing Product Portfolio Table 86. NSF International Recent Development Table 87. ALS Limited Company Information Table 88. ALS Limited Business Overview Table 89. ALS Limited Health Product Testing Revenue (US$ Million) and Gross Margin (2021-2026) Table 90. ALS Limited Health Product Testing Product Portfolio Table 91. ALS Limited Recent Development Table 92. QIMA (AsiaInspection) Company Information Table 93. QIMA (AsiaInspection) Business Overview Table 94. QIMA (AsiaInspection) Health Product Testing Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 95. QIMA (AsiaInspection) Health Product Testing Product Portfolio Table 96. QIMA (AsiaInspection) Recent Development Table 97. TÜV Rheinland Group Company Information Table 98. TÜV Rheinland Group Business Overview Table 99. TÜV Rheinland Group Health Product Testing Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 100. TÜV Rheinland Group Health Product Testing Product Portfolio Table 101. TÜV Rheinland Group Recent Development Table 102. Research Programs/Design for This Report Table 103. Authors List of This Report Table 104. Secondary Sources Table 105. Primary Sources List of Figures Figure 1. Health Product Testing Product Image Figure 2. Global Health Product Testing Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Health Product Testing Market Size (2021-2032) & (US$ Million) Figure 4. Global Health Product Testing Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Ingredient Testing Image Figure 8. Heavy Metal and Hazardous Substance Detection Image Figure 9. Microbial Indicator Detection Image Figure 10. Physical and Chemical Indicator Monitoring Image Figure 11. Toxicology Experiments Image Figure 12. Functional Verification Image Figure 13. Global Health Product Testing Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 14. Global Health Product Testing Sales Value Share 2021 VS 2025 VS 2032 Figure 15. Global Health Product Testing Sales Value Share by Type (2021-2032) Figure 16. Personal Image Figure 17. Enterprise Image Figure 18. Global Health Product Testing Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 19. Global Health Product Testing Sales Value Share 2021 VS 2025 VS 2032 Figure 20. Global Health Product Testing Sales Value Share by Application (2021-2032) Figure 21. Global Health Product Testing Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 22. Global Health Product Testing Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 23. North America Health Product Testing Sales Value (2021-2032) & (US$ Million) Figure 24. North America Health Product Testing Sales Value Share by Country (%), 2025 VS 2032 Figure 25. Europe Health Product Testing Sales Value (2021-2032) & (US$ Million) Figure 26. Europe Health Product Testing Sales Value Share by Country (%), 2025 VS 2032 Figure 27. Asia-Pacific Health Product Testing Sales Value (2021-2032) & (US$ Million) Figure 28. Asia-Pacific Health Product Testing Sales Value Share by Country (%), 2025 VS 2032 Figure 29. South America Health Product Testing Sales Value (2021-2032) & (US$ Million) Figure 30. South America Health Product Testing Sales Value Share by Country (%), 2025 VS 2032 Figure 31. Middle East & Africa Health Product Testing Sales Value (2021-2032) & (US$ Million) Figure 32. Middle East & Africa Health Product Testing Sales Value Share by Country (%), 2025 VS 2032 Figure 33. USA Health Product Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 34. USA Health Product Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 35. USA Health Product Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 36. Canada Health Product Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 37. Canada Health Product Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 38. Canada Health Product Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 39. Mexico Health Product Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 40. Mexico Health Product Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 41. Mexico Health Product Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 42. Germany Health Product Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. Germany Health Product Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. Germany Health Product Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. France Health Product Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. France Health Product Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. France Health Product Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. U.K. Health Product Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. U.K. Health Product Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. U.K. Health Product Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. Italy Health Product Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. Italy Health Product Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. Italy Health Product Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. Spain Health Product Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. Spain Health Product Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. Spain Health Product Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. Russia Health Product Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. Russia Health Product Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. Russia Health Product Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Netherlands Health Product Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Netherlands Health Product Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Netherlands Health Product Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. Nordic Countries Health Product Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. Nordic Countries Health Product Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. Nordic Countries Health Product Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. China Health Product Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. China Health Product Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. China Health Product Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. Japan Health Product Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. Japan Health Product Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. Japan Health Product Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. South Korea Health Product Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. South Korea Health Product Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. South Korea Health Product Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. India Health Product Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. India Health Product Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. India Health Product Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. Australia Health Product Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. Australia Health Product Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. Australia Health Product Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. Southeast Asia Health Product Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. Southeast Asia Health Product Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. Southeast Asia Health Product Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. Brazil Health Product Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. Brazil Health Product Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. Brazil Health Product Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Argentina Health Product Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Argentina Health Product Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Argentina Health Product Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Chile Health Product Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Chile Health Product Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Chile Health Product Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Colombia Health Product Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Colombia Health Product Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Colombia Health Product Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Peru Health Product Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Peru Health Product Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Peru Health Product Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Saudi Arabia Health Product Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Saudi Arabia Health Product Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Saudi Arabia Health Product Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. Israel Health Product Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. Israel Health Product Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. Israel Health Product Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. UAE Health Product Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. UAE Health Product Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. UAE Health Product Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Turkey Health Product Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Turkey Health Product Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Turkey Health Product Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. Iran Health Product Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. Iran Health Product Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. Iran Health Product Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. Egypt Health Product Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 115. Egypt Health Product Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 116. Egypt Health Product Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 117. Years Considered Figure 118. Research Process Figure 119. Key Executives Interviewed

Scope & coverage.

Types
  • Ingredient Testing
  • Heavy Metal and Hazardous Substance Detection
  • Microbial Indicator Detection
  • Physical and Chemical Indicator Monitoring
  • Toxicology Experiments
  • Functional Verification
Applications
  • Personal
  • Enterprise
Companies covered
  • CPT Labs
  • Bureau Veritas
  • Eurofins Scientific
  • ESR
  • UL (Underwriters Laboratories)
  • Intertek Group
  • SGS SA
  • TUV SUD
  • NSF International
  • ALS Limited
  • QIMA (AsiaInspection)
  • TÜV Rheinland Group

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Health Product Testing Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Health Product Testing Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Health Product Testing Market Dynamics
  1. 2.1 Health Product Testing Industry Trends
  2. 2.2 Health Product Testing Industry Drivers
  3. 2.3 Health Product Testing Industry Opportunities and Challenges
  4. 2.4 Health Product Testing Industry Restraints
3 Health Product Testing Market by Company
  1. 3.1 Global Health Product Testing Company Revenue Ranking in 2025
  2. 3.2 Global Health Product Testing Revenue by Company (2021-2026)
  3. 3.3 Global Health Product Testing Company Ranking (2024-2026)
  4. 3.4 Global Health Product Testing Company Manufacturing Base and Headquarters
  5. 3.5 Global Health Product Testing Company Product Type and Application
  6. 3.6 Global Health Product Testing Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Health Product Testing Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Health Product Testing Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Health Product Testing Market by Type
  1. 4.1 Health Product Testing Type Introduction
  2. 4.1.1 Ingredient Testing
  3. 4.1.2 Heavy Metal and Hazardous Substance Detection
  4. 4.1.3 Microbial Indicator Detection
  5. 4.1.4 Physical and Chemical Indicator Monitoring
  6. 4.1.5 Toxicology Experiments
  7. 4.1.6 Functional Verification
  8. 4.2 Global Health Product Testing Sales Value by Type
  9. 4.2.1 Global Health Product Testing Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.2.2 Global Health Product Testing Sales Value by Type (2021-2032)
  11. 4.2.3 Global Health Product Testing Sales Value Share by Type (2021-2032)
5 Health Product Testing Market by Application
  1. 5.1 Health Product Testing Application Introduction
  2. 5.1.1 Personal
  3. 5.1.2 Enterprise
  4. 5.2 Global Health Product Testing Sales Value by Application
  5. 5.2.1 Global Health Product Testing Sales Value by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Health Product Testing Sales Value by Application (2021-2032)
  7. 5.2.3 Global Health Product Testing Sales Value Share by Application (2021-2032)
6 Health Product Testing Regional Value Analysis
  1. 6.1 Global Health Product Testing Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Health Product Testing Sales Value by Region (2021-2032)
  3. 6.2.1 Global Health Product Testing Sales Value by Region: 2021-2026
  4. 6.2.2 Global Health Product Testing Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Health Product Testing Sales Value (2021-2032)
  7. 6.3.2 North America Health Product Testing Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Health Product Testing Sales Value (2021-2032)
  10. 6.4.2 Europe Health Product Testing Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Health Product Testing Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Health Product Testing Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Health Product Testing Sales Value (2021-2032)
  16. 6.6.2 South America Health Product Testing Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Health Product Testing Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Health Product Testing Sales Value Share by Country, 2025 VS 2032
7 Health Product Testing Country-level Value Analysis
  1. 7.1 Global Health Product Testing Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Health Product Testing Sales Value by Country (2021-2032)
  3. 7.2.1 Global Health Product Testing Sales Value by Country (2021-2026)
  4. 7.2.2 Global Health Product Testing Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Health Product Testing Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Health Product Testing Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Health Product Testing Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Health Product Testing Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Health Product Testing Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Health Product Testing Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Health Product Testing Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Health Product Testing Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Health Product Testing Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Health Product Testing Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Health Product Testing Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Health Product Testing Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Health Product Testing Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Health Product Testing Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Health Product Testing Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Health Product Testing Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Health Product Testing Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Health Product Testing Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Health Product Testing Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Health Product Testing Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Health Product Testing Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Health Product Testing Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Health Product Testing Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Health Product Testing Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Health Product Testing Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Health Product Testing Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Health Product Testing Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Health Product Testing Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Health Product Testing Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Health Product Testing Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Health Product Testing Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Health Product Testing Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Health Product Testing Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Health Product Testing Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Health Product Testing Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Health Product Testing Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Health Product Testing Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Health Product Testing Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Health Product Testing Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Health Product Testing Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Health Product Testing Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Health Product Testing Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Health Product Testing Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Health Product Testing Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Health Product Testing Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Health Product Testing Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Health Product Testing Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Health Product Testing Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Health Product Testing Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Health Product Testing Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Health Product Testing Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Health Product Testing Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Health Product Testing Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Health Product Testing Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Health Product Testing Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Health Product Testing Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Health Product Testing Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Health Product Testing Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Health Product Testing Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Health Product Testing Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Health Product Testing Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Health Product Testing Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Health Product Testing Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Health Product Testing Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Health Product Testing Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Health Product Testing Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Health Product Testing Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Health Product Testing Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Health Product Testing Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Health Product Testing Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Health Product Testing Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Health Product Testing Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Health Product Testing Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Health Product Testing Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Health Product Testing Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Health Product Testing Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Health Product Testing Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Health Product Testing Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Health Product Testing Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Health Product Testing Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Health Product Testing Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Health Product Testing Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Health Product Testing Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Health Product Testing Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 CPT Labs
  2. 8.1.1 CPT Labs Company Information
  3. 8.1.2 CPT Labs Business Overview
  4. 8.1.3 CPT Labs Health Product Testing Revenue and Gross Margin (2021-2026)
  5. 8.1.4 CPT Labs Health Product Testing Product Portfolio
  6. 8.1.5 CPT Labs Recent Developments
  7. 8.2 Bureau Veritas
  8. 8.2.1 Bureau Veritas Company Information
  9. 8.2.2 Bureau Veritas Business Overview
  10. 8.2.3 Bureau Veritas Health Product Testing Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Bureau Veritas Health Product Testing Product Portfolio
  12. 8.2.5 Bureau Veritas Recent Developments
  13. 8.3 Eurofins Scientific
  14. 8.3.1 Eurofins Scientific Company Information
  15. 8.3.2 Eurofins Scientific Business Overview
  16. 8.3.3 Eurofins Scientific Health Product Testing Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Eurofins Scientific Health Product Testing Product Portfolio
  18. 8.3.5 Eurofins Scientific Recent Developments
  19. 8.4 ESR
  20. 8.4.1 ESR Company Information
  21. 8.4.2 ESR Business Overview
  22. 8.4.3 ESR Health Product Testing Revenue and Gross Margin (2021-2026)
  23. 8.4.4 ESR Health Product Testing Product Portfolio
  24. 8.4.5 ESR Recent Developments
  25. 8.5 UL (Underwriters Laboratories)
  26. 8.5.1 UL (Underwriters Laboratories) Company Information
  27. 8.5.2 UL (Underwriters Laboratories) Business Overview
  28. 8.5.3 UL (Underwriters Laboratories) Health Product Testing Revenue and Gross Margin (2021-2026)
  29. 8.5.4 UL (Underwriters Laboratories) Health Product Testing Product Portfolio
  30. 8.5.5 UL (Underwriters Laboratories) Recent Developments
  31. 8.6 Intertek Group
  32. 8.6.1 Intertek Group Company Information
  33. 8.6.2 Intertek Group Business Overview
  34. 8.6.3 Intertek Group Health Product Testing Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Intertek Group Health Product Testing Product Portfolio
  36. 8.6.5 Intertek Group Recent Developments
  37. 8.7 SGS SA
  38. 8.7.1 SGS SA Company Information
  39. 8.7.2 SGS SA Business Overview
  40. 8.7.3 SGS SA Health Product Testing Revenue and Gross Margin (2021-2026)
  41. 8.7.4 SGS SA Health Product Testing Product Portfolio
  42. 8.7.5 SGS SA Recent Developments
  43. 8.8 TUV SUD
  44. 8.8.1 TUV SUD Company Information
  45. 8.8.2 TUV SUD Business Overview
  46. 8.8.3 TUV SUD Health Product Testing Revenue and Gross Margin (2021-2026)
  47. 8.8.4 TUV SUD Health Product Testing Product Portfolio
  48. 8.8.5 TUV SUD Recent Developments
  49. 8.9 NSF International
  50. 8.9.1 NSF International Company Information
  51. 8.9.2 NSF International Business Overview
  52. 8.9.3 NSF International Health Product Testing Revenue and Gross Margin (2021-2026)
  53. 8.9.4 NSF International Health Product Testing Product Portfolio
  54. 8.9.5 NSF International Recent Developments
  55. 8.10 ALS Limited
  56. 8.10.1 ALS Limited Company Information
  57. 8.10.2 ALS Limited Business Overview
  58. 8.10.3 ALS Limited Health Product Testing Revenue and Gross Margin (2021-2026)
  59. 8.10.4 ALS Limited Health Product Testing Product Portfolio
  60. 8.10.5 ALS Limited Recent Developments
  61. 8.11 QIMA (AsiaInspection)
  62. 8.11.1 QIMA (AsiaInspection) Company Information
  63. 8.11.2 QIMA (AsiaInspection) Business Overview
  64. 8.11.3 QIMA (AsiaInspection) Health Product Testing Revenue and Gross Margin (2021-2026)
  65. 8.11.4 QIMA (AsiaInspection) Health Product Testing Product Portfolio
  66. 8.11.5 QIMA (AsiaInspection) Recent Developments
  67. 8.12 TÜV Rheinland Group
  68. 8.12.1 TÜV Rheinland Group Company Information
  69. 8.12.2 TÜV Rheinland Group Business Overview
  70. 8.12.3 TÜV Rheinland Group Health Product Testing Revenue and Gross Margin (2021-2026)
  71. 8.12.4 TÜV Rheinland Group Health Product Testing Product Portfolio
  72. 8.12.5 TÜV Rheinland Group Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst